Granules India

India-based vertically-integrated pharmaceutical manufacturer making finished dosages, APIs, and PFIs. Entered the peptide space in 2025 through acquisition of Senn Chemicals AG, a Switzerland-based peptide CDMO. Developing GLP-1 based APIs with a new peptide manufacturing facility. Manufacturing facilities in India, US, and now Switzerland.

Granules India is listed as a CDMO in the peptide supply chain, serving Asia markets from India / Switzerland. As a direct manufacturer, this supplier controls its own production process from synthesis through purification and quality control release testing. Verification is supported by 1 independent source, including documentation review and cross-referencing against public records. This supplier has a strong confidence score, indicating a high level of verification and reliability for B2B sourcing.